RLN2 and breast cancer: Oligonucleotide primers employed at melting temperatures (TM in °C) used to determine the expression of RLN2, human RXFP1 relaxin receptor (RXFP1), S100A4 and 18S transcripts in human breast cancer cell lines and xenograft tumours.